Expresso has reported on what it describes as a "sugar forest" that may open the way to new therapies for conditions such as psoriasis, lupus and Crohn's disease. The Portuguese outlet published the report on Monday, 2 November 2026. The available summary does not name the researchers, the institutions involved or the specific mechanism behind the findings.
According to Expresso, the work centres on a "forest of sugars" and its potential to support new treatment approaches for these diseases. Psoriasis, lupus and Crohn's disease are all conditions in which the immune system plays a central role, though the source material does not state how the sugar-related research connects to them.
The report was published under Expresso's science and health coverage. Beyond the headline and summary, no further details were available at the time of writing, including whether the work has been peer-reviewed or how far it has progressed toward clinical testing.
What to watch: Further reporting from Expresso and the underlying study, if published, should clarify who conducted the research, what exactly the "sugar forest" refers to, and how close the findings are to any therapy that could be tested in patients.